10-K: Diversified Healthcare Trust Navigates Transition with Mixed 2025 Results

Diversified Healthcare Trust reported a reduced net loss and increased total NOI in 2025, driven by strong SHOP performance and strategic asset sales, despite a decline in FFO and negative operating cash flow.

Summary

• Diversified Healthcare Trust (DHC) reported a net loss of $(285.9) million for the year ended December 31, 2025, an improvement from $(370.3) million in 2024.
• Total revenues increased by 2.8% to $1,537.9 million in 2025 from $1,495.4 million in 2024.
• Total Net Operating Income (NOI) rose by 7.6% to $278.5 million in 2025, up from $258.9 million in 2024.
• The Senior Housing Operating Portfolio (SHOP) segment's NOI increased by 31.3% to $139.3 million, with occupancy rising to 81.0% (from 79.3% in 2024) and average monthly rates reaching $5,455 (from $5,193 in 2024).
• The Medical Office and Life Science Portfolio segment's NOI decreased by 6.5% to $108.1 million, though occupancy improved to 91.2% (from 82.2% in 2024).
• Funds From Operations (FFO) decreased significantly to $2.6 million in 2025 from $25.6 million in 2024.
• Normalized FFO, however, increased substantially to $64.4 million in 2025 from $19.7 million in 2024.
• Net cash used in operating activities was $(19.6) million in 2025, a notable shift from $112.2 million provided in 2024, primarily due to $152.9 million in accreted interest paid on senior secured notes.
• DHC generated $589.2 million in net proceeds from the sale of 69 properties in 2025, contributing to a $117.7 million gain on sale of properties.
• The company redeemed $940.5 million of senior secured notes due 2026 and $380.0 million of 9.75% senior unsecured notes due 2025, incurring a $42.5 million loss on early extinguishment of debt.
• DHC issued $375.0 million in 7.25% senior secured notes due 2030 in September 2025 and obtained a new $150.0 million revolving credit facility in June 2025.
• Credit ratings were upgraded by Moody's (Caa3 to Caa1) and Standard & Poor's (CCC+ to B-) in 2025.
• Impairment charges on assets totaled $165.7 million in 2025, up from $70.7 million in 2024, primarily affecting medical office/life science properties and senior living communities.
• The quarterly cash distribution rate to common shareholders remained at $0.01 per share.
• DHC completed the transition of 116 senior living communities from Five Star Senior Living to seven new third-party managers by December 31, 2025, incurring $10.4 million in transition costs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a mixed filing. While operational improvements in the SHOP segment and strategic debt reduction are positive, the significant decline in FFO and negative operating cash flow for 2025, coupled with substantial impairment charges, indicate ongoing challenges despite an optimistic future outlook.

Positives

• Net loss improved significantly to $(285.9) million in 2025 from $(370.3) million in 2024.
• Total Net Operating Income (NOI) increased by 7.6% to $278.5 million in 2025.
• The SHOP segment demonstrated strong performance with a 31.3% increase in NOI, driven by higher occupancy (81.0%) and average monthly rates ($5,455).
• Medical Office and Life Science Portfolio achieved a 12.4% weighted average rental rate change on new and renewal leases in 2025.
• Normalized FFO saw a substantial increase to $64.4 million in 2025 from $19.7 million in 2024.
• Successful disposition of 69 properties generated $589.2 million in net proceeds and a $117.7 million gain on sale in 2025.
• Significant debt reduction was achieved through the redemption of $940.5 million in senior secured notes and $380.0 million in senior unsecured notes.
• Credit ratings were upgraded by both Moody's (Caa3 to Caa1) and Standard & Poor's (CCC+ to B-) in 2025, reflecting improved creditworthiness.
• A new $150.0 million revolving credit facility was secured in June 2025, providing additional liquidity with no outstanding borrowings as of February 23, 2026.
• Equity in net earnings of investees increased substantially to $36.8 million in 2025, including cash distributions from the Seaport JV and AlerisLife.
• A gain of $7.5 million was recognized from insurance recoveries related to hurricane damage at senior living communities.

Negatives

• Net cash used in operating activities was $(19.6) million in 2025, a significant decline from $112.2 million provided in 2024, primarily due to $152.9 million in accreted interest payments.
• Funds From Operations (FFO) decreased to $2.6 million in 2025 from $25.6 million in 2024.
• Medical Office and Life Science Portfolio NOI decreased by 6.5% in 2025.
• General and administrative expenses increased by 71.6% to $45.5 million in 2025, largely due to a $17.9 million incentive management fee to RMR.
• Impairment of assets surged to $165.7 million in 2025, indicating a reduction in the estimated fair value of certain properties.
• A significant loss of $42.5 million was incurred on the modification or early extinguishment of debt in 2025.
• Interest and other income decreased by 34.8% in 2025 due to lower average invested cash balances and interest rates.
• The company continues to experience variability and increases in labor, insurance, and food costs within its SHOP segment.
• Venture capital funding in the life science sector has significantly declined from 2023-2025, leading to softening demand and rising vacancy rates in major markets.
• The quarterly cash distribution rate to common shareholders remains low at $0.01 per share, with no immediate plans for an increase.

Risks

• Unfavorable market and commercial real estate industry conditions, including interest rate volatility, inflation, supply chain disruptions, and economic downturns, could materially impact operations.
• Dependence on third-party managers for senior living communities exposes the company to operational risks and potential conflicts of interest.
• Significant competition for tenants, residents, and acquisition opportunities could reduce rents and property values.
• High debt levels and the ability to refinance maturing debt at favorable terms remain a risk, with covenants potentially restricting operational flexibility and distributions.
• Inability to renew leases or relet properties without significant costs or rent decreases, especially for specialized medical office and life science properties.
• Risks associated with property development, redevelopment, and repositioning, including cost overruns, delays, and failure to achieve targeted returns due to inflation and labor shortages.
• Exposure to environmental risks and liabilities, including hazardous substances and costs associated with remediation.
• Adverse weather, natural disasters, and impacts from global climate change could severely damage properties and lead to uninsured losses.
• Reliance on information technology and systems of RMR and managers creates cybersecurity risks, including potential breaches and disruptions.
• Management structure and agreements with RMR, and relationships with related parties, may create conflicts of interest or the perception thereof.
• Sustainability initiatives and evolving market expectations may impose additional costs and reputational risks.
• The Board of Trustees can change operational, financing, and investment policies without shareholder approval, potentially increasing leverage.
• REIT distribution requirements may limit cash retention for growth and debt repayment.
• Potential for guarantees to be voided or subordinated under bankruptcy law.
• Lack of a public market for certain notes may affect liquidity and trading prices.
• Downgrades in credit ratings could adversely affect the market price of notes and increase the cost of capital.
• Inability to raise funds to repurchase notes upon a change of control event.
• Legislative or other actions affecting REITs could materially and adversely affect the company and its shareholders.
• REIT dividends generally do not qualify for reduced tax rates, potentially making the stock less attractive to some investors.
• Failure of Taxable REIT Subsidiary (TRS) arrangements to comply with REIT rules could lead to significant penalty taxes.
• Increased risk of dissident shareholder activities due to perceived conflicts of interest.
• Limitations on shareholder rights to take action against Trustees and officers.
• Bylaws designate the Circuit Court for Baltimore City, Maryland as the exclusive forum for certain shareholder disputes, potentially limiting judicial options.
• Disputes with RMR may be subject to mandatory arbitration proceedings.

Future Outlook

DHC anticipates continued increases in occupancy and average monthly rates in its Senior Housing Operating Portfolio (SHOP) over the next 12 to 24 months, driven by improving market fundamentals and constrained supply. The company expects moderation in labor, insurance, and food cost increases, which should allow managers to raise rates in excess of costs, leading to improved returns. DHC plans to continue investing in properties, including redevelopment projects, to enhance market positioning and returns, while potentially deferring some projects to preserve liquidity. The company expects to fund future obligations through operating cash flows and available cash, and believes it will have reasonable access to debt and equity financing for operations, debt repayment, and investments.

Management Comments

• We are encouraged by positive trends, including increases in rates, margins and occupancy in our SHOP segment.
• Additionally, we expect that favorable supply and demand dynamics in the senior living industry will enable our managers to continue to grow occupancy and drive positive performance.
• While certain costs, primarily labor, insurance and food costs, have increased, we expect these cost increases to moderate, which will provide our managers the opportunity to increase rates in excess of increases in costs, resulting in improving returns to us.
• Our strategy to drive positive performance includes analyzing non-performing communities for potential disposition or transition to different operators.
• We believe that the aging of the U.S. population benefits our portfolio of healthcare real estate.
• We believe there is a favorable mix of increased demand and limited supply for senior living communities, which we expect will benefit us and our existing portfolio of senior living communities in the future.
• We plan to seek to profit from this demand in the future by, over time, investing in our properties, acquiring additional properties and entering into management and lease arrangements with qualified managers, operators and tenants which enhance our cash flow and generate returns that exceed our operating and capital costs to us.
• We also seek to selectively sell properties from time to time when we determine our continued ownership or ongoing required capital expenditures will not achieve desired returns, when we believe there is an opportunity to reduce leverage, when we believe we have maximized returns or when we believe we can successfully pursue more desirable opportunities than retaining these properties.
• Additionally, we seek to selectively develop, redevelop or reposition our properties when we believe the returns will be satisfactory.

Industry Context

StockSavvy.ai notes that Diversified Healthcare Trust operates within a resilient healthcare real estate sector, which constitutes approximately 18% of the U.S. GDP and is projected to exceed 20% by 2033. The aging U.S. population, particularly the 75+ demographic, is a significant tailwind for DHC's senior living portfolio, with this cohort projected to grow 4% annually between 2025 and 2035. The senior living industry is currently characterized by historically low inventory growth (0.5% in Q4 2025) and healthy absorption (2.8% in Q4 2025), suggesting a favorable supply-demand dynamic. In the medical office sector, the trend towards outpatient care and multi-practice buildings aligns with broader healthcare delivery shifts. However, the life science sector faces headwinds from declining venture capital funding and increased vacancy rates due to record new construction in 2024, which could impact DHC's life science properties. The company also acknowledges increased scrutiny on private equity and REIT investment in healthcare, which could lead to new regulatory challenges.

Comparison to Industry Standards

• The reported annual inventory growth of 0.5% and absorption rate of 2.8% for senior living communities in Q4 2025, as per NIC data, indicate a favorable supply-demand balance for DHC's SHOP segment compared to the broader senior housing market.
• The medical office sector's trend towards outpatient care and multi-practice buildings, as noted in the filing, aligns with global healthcare shifts, suggesting DHC's Medical Office and Life Science Portfolio is positioned within a growing segment of healthcare delivery.
• The decline in venture capital funding and rising vacancy rates in major life science markets, as observed in the industry, suggest that DHC's life science properties may face similar market pressures as other players in this specialized real estate segment.
• DHC's occupancy rates of 81.0% for SHOP and 91.2% for Medical Office and Life Science Portfolio can be benchmarked against industry averages for comparable REITs, though specific competitor data is not provided in the filing for direct comparison.

Management Changes

Corporate Governance

Legal Proceedings

• The company is currently not a party to any litigation which it expects to have a material adverse effect on its business.
• The senior living and healthcare industries are subject to extensive litigation and regulatory/government proceedings, which could expose the company and its managers/tenants to significant expenses and liabilities.

Related Party Transactions

• DHC has ongoing relationships and transactions with The RMR Group LLC (RMR), RMR Inc., AlerisLife Inc. (including Five Star Senior Living), and other entities managed by RMR or its subsidiaries.
• Adam D. Portnoy, Chair of DHC's Board of Trustees and a Managing Trustee, is the controlling shareholder of ABP Trust (controlling shareholder of RMR Inc.), and holds key leadership positions at RMR Inc., RMR, and AlerisLife.
• Other DHC executive officers (Christopher J. Bilotto, Matthew C. Brown, Anthony Paula) also hold executive positions at RMR or its affiliates, creating potential conflicts of interest.
• ABP Trust and Adam D. Portnoy beneficially owned 9.8% of DHC's outstanding common shares as of December 31, 2025.
• DHC owns approximately 34.0% of AlerisLife's outstanding common shares (directly and indirectly through a TRS).
• The Master Management Agreement with Five Star (an AlerisLife operating division) was terminated in December 2025 as part of AlerisLife's business wind-down, following the transition of 116 senior living communities to new managers.
• DHC received cash dividends of $17.0 million and $3.4 million from AlerisLife in February and July 2025, respectively, and an additional $27.2 million in January 2026.
• RMR provides management services to DHC's unconsolidated joint ventures (Seaport JV and LSMD JV).
• DHC leases office space to RMR, generating rental income of $423 thousand in 2025.
• DHC awarded 950,895 common shares to its officers and other RMR employees in 2025 as part of equity compensation.
• DHC purchased 276,078 common shares in 2025 from Trustees, officers, and RMR employees to satisfy tax withholding obligations related to vested share awards.

Stakeholder Impact

• Shareholders: Face continued low quarterly cash distributions ($0.01 per share), with uncertainty regarding future increases or potential elimination. The mixed financial results and ongoing transition could impact share price volatility. Potential for dilution from future equity offerings is noted.
• Employees (RMR-managed): DHC relies on RMR for personnel. Changes in management agreements and property transitions could affect employment stability and compensation structures for those managing DHC's properties.
• Customers/Residents (Senior Living): Experienced management transitions at 116 communities, which could lead to temporary disruptions. Potential for increased rates due to pricing strategies, but also exposure to rising operating costs.
• Tenants (Medical Office/Life Science): Benefit from positive rental rate changes on new and renewed leases, but face softening demand and rising vacancy in the broader life science market.
• Creditors: Benefit from DHC's significant debt reduction efforts and improved credit ratings. However, high overall debt levels and potential for default under covenants remain a consideration.
• Suppliers: May be impacted by ongoing supply chain disruptions and commodity price inflation, affecting costs for property operations and redevelopment projects.

Next Steps

• Continue investing capital in properties, including redevelopment projects, to enhance market positioning and increase returns.
• Acquire additional properties to grow the business.
• Enter into management and lease arrangements with qualified managers, operators, and tenants to enhance cash flow.
• Selectively sell properties to reduce leverage, improve liquidity, and strategically rebalance the investment portfolio.
• Develop, redevelop, or reposition properties when satisfactory returns are expected.
• Exercise the purchase option for two properties securing finance leases, with closing expected in April 2026.
• Receive liquidating distributions from AlerisLife in 2026 or future taxable years as part of its wind-down.

Key Dates

Recommendation

Diversified Healthcare Trust is in a significant transitional phase, marked by strategic debt reduction, credit rating upgrades, and a major shift in senior living management. While the improved net loss and strong SHOP segment performance are positive, the decline in FFO and negative operating cash flow for 2025, coupled with substantial impairment charges, indicate underlying operational challenges. The long-term demographic tailwinds for healthcare real estate are favorable, but the company's ability to consistently translate these into improved profitability and cash flow remains to be proven. A seasoned investor would likely 'hold' to observe the sustained impact of the management transitions, the moderation of operating costs, and the effectiveness of capital deployment strategies before making a more definitive investment decision.

Keywords

Diversified Healthcare Trust, REIT, Senior Living, Medical Office Properties, Life Science Properties, Healthcare Real Estate, 10-K, Financial Performance, Net Operating Income, Funds From Operations, Debt Management, Property Dispositions, Occupancy Rates, Leasing Activity, AlerisLife, RMR Group, Credit Ratings, Capital Expenditures, Demographics, REIT Taxation, Cybersecurity, ESG